Free CBIC CIC Practice Exam with Questions & Answers | Set: 8

Primary prevention focuses on preventing the initial occurrence of disease or injury before it manifests, distinguishing it from secondary (early detection) and tertiary (mitigation of complications) prevention. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes the "Prevention and Control of Infectious Diseases" domain, which includes collaboration with public health agencies to implement preventive strategies, aligning with the Centers for Disease Control and Prevention (CDC) framework for infection prevention. The question requires identifying the activity that best fits primary prevention efforts.

Option C, "Promoting vaccination of health care workers and patients," is the correct answer. Vaccination is a cornerstone of primary prevention, as it prevents the onset of vaccine-preventable diseases (e.g., influenza, hepatitis B, measles) by inducing immunity before exposure. The CDC’s "Immunization of Health-Care Personnel" (2011) and "General Recommendations on Immunization" (2021) highlight the role of vaccination in protecting both healthcare workers and patients, reducing community transmission and healthcare-associated infections. Collaboration with public health agencies, which often oversee vaccination campaigns and supply distribution, enhances this effort, making it a proactive primary prevention strategy.

Option A, "Conducting outbreak investigations," is a secondary prevention activity. Outbreak investigations occur after cases are identified to control spread and mitigate impact, focusing on containment rather than preventing initial disease occurrence. The CDC’s "Principles of Epidemiology in Public Health Practice" (3rd Edition, 2012) classifies this as a response to an existing problem. Option B, "Performing surveillance for tuberculosis through tuberculin skin test," is also secondary prevention. Surveillance, including tuberculin skin testing, aims to detect latent or active tuberculosis early to prevent progression or transmission, not to prevent initial infection. The CDC’s "Guidelines for Preventing the Transmission of Mycobacterium tuberculosis" (2005) supports this as a screening tool. Option D, "Offering blood and body fluid post-exposure prophylaxis," is tertiary prevention. Post-exposure prophylaxis (e.g., for HIV or hepatitis B) is administered after potential exposure to prevent disease development, focusing on mitigating consequences rather than preventing initial exposure, as outlined in the CDC’s "Updated U.S. Public Health Service Guidelines" (2013).

The CBIC Practice Analysis (2022) and CDC guidelines prioritize vaccination as a primary prevention strategy, and collaboration with public health agencies amplifies its reach. Option C best reflects this preventive focus, making it the correct choice.

The scenario describes an outbreak of Aspergillus infections among three patients on an oncology unit following recent renovations, with the infections suspected to be facility-acquired. Aspergillus is a mold commonly associated with environmental sources, particularly airborne spores, and its presence in immunocompromised patients (e.g., oncology patients) poses a significant risk. The infection preventionist must identify the appropriate environmental microbiological monitoring strategy, guided by the Certification Board of Infection Control and Epidemiology (CBIC) and CDC recommendations. Let’s evaluate each option:

A. Air: Aspergillus species are ubiquitous molds that thrive in soil, decaying vegetation, and construction dust, and they are primarily transmitted via airborne spores. Renovations can disturb these spores, leading to aerosolization and inhalation by vulnerable patients. Culturing the air using methods such as settle plates, air samplers, or high-efficiency particulate air (HEPA) filtration monitoring is a standard practice to detect Aspergillus during construction or post-renovation in healthcare settings, especially oncology units where patients are at high risk for invasive aspergillosis. This aligns with CBIC’s emphasis on environmental monitoring for airborne pathogens, making it the most appropriate choice.

B. Ice: Ice can be a source of contamination with bacteria (e.g., Pseudomonas, Legionella) or other pathogens if improperly handled or stored, but it is not a typical reservoir for Aspergillus, which is a mold requiring organic material and moisture for growth. While ice safety is important in infection control, culturing ice is irrelevant to an Aspergillus outbreak linked to renovations and is not a priority in this context.

C. Carpet: Carpets can harbor dust, mold, and other microorganisms, especially in high-traffic or poorly maintained areas. Aspergillus spores could theoretically settle in carpet during renovations, but carpets are not a primary source of airborne transmission unless disturbed (e.g., vacuuming). Culturing carpet might be a secondary step if air sampling indicates widespread contamination, but it is less direct and less commonly recommended as the initial monitoring site compared to air sampling.

D. Aerators: Aerators (e.g., faucet aerators) can harbor waterborne pathogens like Pseudomonas or Legionella due to biofilm formation, but Aspergillus is not typically associated with water systems unless there is significant organic contamination or aerosolization from water sources (e.g., cooling towers). Culturing aerators is relevant for waterborne outbreaks, not for an Aspergillus outbreak linked to renovations, making this option inappropriate.

The best answer is A, culturing the air, as Aspergillus is an airborne pathogen, and renovations are a known risk factor for spore dispersal in healthcare settings. This monitoring strategy allows the infection preventionist to confirm the source, assess the extent of contamination, and implement control measures (e.g., enhanced filtration, construction barriers) to protect patients. This is consistent with CBIC and CDC guidelines for managing fungal outbreaks in high-risk units.

CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain IV: Environment of Care, which recommends air sampling for Aspergillus during construction-related outbreaks.

CBIC Examination Content Outline, Domain III: Prevention and Control of Infectious Diseases, which includes environmental monitoring for facility-acquired infections.

CDC Guidelines for Environmental Infection Control in Healthcare Facilities (2022), which advocate air culturing to detect Aspergillus post-renovation in immunocompromised patient areas.

Requiring influenza vaccination as a condition of employment has consistently been shown to be the most effective method to increase compliance among healthcare personnel.

The APIC/JCR Workbook recommends this as a gold standard:

"Some organizations have adopted policies requiring annual vaccination as a condition of employment unless medically contraindicated".

CDC and APIC also support this method for maximizing coverage and protecting vulnerable populations.

The CBIC Certified Infection Control Exam Study Guide (6th edition) clearly distinguishes true infection from pseudo-infection and colonization, particularly when interpreting urine culture results. A pseudo-infection refers to a positive laboratory result that does not represent a true clinical infection and is often associated with asymptomatic bacteriuria, specimen contamination, or improper collection.

When a patient has a positive urine culture but reports no urinary or systemic symptoms, the most accurate interpretation is that the finding represents colonization or a pseudo-infection rather than a true urinary tract infection (UTI). The Study Guide emphasizes that UTIs must meet both microbiologic and clinical criteria. Symptoms such as dysuria, urinary frequency, urgency, suprapubic tenderness, flank pain, or costovertebral angle tenderness are required to support a diagnosis of infection.

Options A, C, and D all describe symptoms consistent with upper or lower urinary tract infection and therefore suggest true infection rather than pseudo-infection. In contrast, the absence of symptoms strongly supports a diagnosis of asymptomatic bacteriuria or pseudo-infection, for which antimicrobial treatment is generally not indicated, except in specific populations (e.g., pregnant patients or those undergoing urologic procedures).

Recognizing pseudo-infection is critical for antimicrobial stewardship, prevention of unnecessary antibiotic use, and accurate infection surveillance—key competencies tested on the CIC® exam.

The CBIC Certified Infection Control Exam Study Guide (6th edition) clearly outlines recommendations for postexposure chemoprophylaxis following invasive meningococcal disease, which is caused by Neisseria meningitidis. This organism is transmitted through direct contact with respiratory secretions or saliva, such as through kissing, sharing eating utensils, or prolonged close household contact.

Household members are considered high-risk close contacts because they have sustained, close exposure to the patient’s respiratory droplets and oral secretions. As a result, they should receive chemoprophylaxis as soon as possible, ideally within 24 hours of identification of the index case, to prevent secondary cases. This recommendation applies regardless of vaccination status.

The other options do not meet criteria for prophylaxis. Healthcare personnel exposed only to urine or feces (Option B) are not at risk, as N. meningitidis is not transmitted via these routes. Casual school contact or sharing supplies (Option C) does not constitute close exposure to respiratory secretions. Athletic teammates (Option D) generally do not require prophylaxis unless there was direct exposure to saliva (e.g., sharing water bottles or mouthguards).

For CIC® exam preparation, it is essential to recognize that chemoprophylaxis is limited to close contacts with direct exposure to respiratory secretions, with household members being the most consistent and clearly defined group requiring prophylaxis.

An infection classified as healthcare-associated (HAI) means it is attributable to receiving care in a healthcare setting—in other words, it was acquired as a result of healthcare exposure rather than being present or incubating before care began. This concept applies across care settings, including long-term care facilities (LTCFs). The CDC describes HAIs as infections patients get while or soon after receiving health care, emphasizing acquisition linked to healthcare delivery rather than simply where the infection is detected. The Association for Professionals in Infection Control and Epidemiology (APIC) similarly explains that HAIs are infections patients can get in a healthcare facility while receiving medical care, which aligns with the idea of being acquired in that setting.

Option B (“identified in the facility”) is incorrect because an infection can be identified in an LTCF even if it was acquired elsewhere (e.g., incubating on admission or acquired during a recent hospitalization). Options A and D use fixed time thresholds; while some surveillance definitions use timing rules (often 48 hours in acute care) to help classify onset, “healthcare-associated” fundamentally implies acquisition related to healthcare exposure, best captured by acquired in the facility in this question

The CBIC Certified Infection Control Exam Study Guide (6th edition) describes the Preparedness and Response Framework for Influenza Pandemics as a structured model that divides a pandemic into distinct intervals to guide public health and healthcare response activities. These intervals include investigation, recognition, initiation, acceleration, deceleration, and preparation for future waves.

The Deceleration of the Pandemic Wave interval is defined by a consistent and sustained decrease in the number of new pandemic influenza cases, hospitalizations, and deaths. This decline reflects the impact of mitigation strategies such as vaccination campaigns, antiviral use, nonpharmaceutical interventions, and the development of population immunity. Although transmission is decreasing, healthcare systems are advised to remain vigilant, as localized transmission may still occur.

Option A describes activities associated with the Investigation Interval, when experts assess the potential public health implications of a novel virus. Option B corresponds to the Recognition Interval, marked by identification of a novel influenza A virus. Option C aligns more closely with the Preparation for Future Waves Interval, when overall activity is low but the risk of resurgence remains.

Understanding these distinctions is critical for infection preventionists, as response priorities shift during each interval. During deceleration, focus transitions from surge response to recovery planning, evaluation of response effectiveness, and preparation for potential subsequent waves—key concepts emphasized in the CIC® exam.

==========

`

The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies inadequate hand hygiene as the most common and significant factor associated with healthcare-associated transmission of methicillin-resistant Staphylococcus aureus (MRSA). MRSA is primarily transmitted via direct contact, most often through the hands of healthcare personnel after contact with colonized or infected patients or contaminated environmental surfaces.

While MRSA-infected or colonized patients serve as reservoirs for the organism, transmission does not occur unless there is a breakdown in infection prevention practices, particularly hand hygiene. Numerous studies and surveillance findings cited in the Study Guide demonstrate that adherence to hand hygiene protocols—before and after patient contact, after contact with bodily fluids, and after contact with the patient environment—is the single most effective measure to reduce MRSA spread within healthcare facilities.

Improper ventilation (Option A) is associated with airborne pathogens, not MRSA, which is not transmitted via the airborne route. MRSA-colonized healthcare workers (Option D) are far less commonly implicated in transmission than transient hand contamination, and routine screening of staff is not recommended except during specific outbreak investigations. Option B describes a reservoir, not the primary mechanism of transmission.

For CIC® exam purposes, this question reinforces a foundational principle of infection prevention: failure to perform appropriate hand hygiene is the leading cause of healthcare-associated MRSA transmission, making it the correct and best answer.

To determine the number of employees who seroconverted (became infected) after a needlestick exposure, we use the given data:

Total Needlestick Injuries: 250

Needlestick Injuries Involving Bloodborne Pathogens: 100

Seroconversion Rate: 2%

Calculation:

Why Other Options Are Incorrect:

A. 1: Incorrect calculation; 2% of 100 is 2, not 1.

C. 5: Overestimates the actual number of infections.

D. 10: Exceeds the calculated value based on given data.

CBIC Infection Control References:

APIC Text, "Occupational Exposure and Seroconversion Risks"​.

APIC Text, "Bloodborne Pathogens and Needlestick Injury Prevention"​

The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies clindamycin as one of the antimicrobials most strongly associated with an increased risk of Clostridioides difficile infection (CDI). Clindamycin has a profound impact on the normal intestinal microbiota, significantly disrupting protective gut flora that ordinarily suppress C. difficile overgrowth. This disruption creates an environment conducive to colonization and toxin production by C. difficile, leading to clinical infection.

Historically, clindamycin was one of the first antibiotics clearly linked to large outbreaks of CDI, and it remains a high-risk agent today. The Study Guide notes that antibiotics with broad anaerobic coverage—including clindamycin, fluoroquinolones, third-generation cephalosporins, and carbapenems—are particularly associated with CDI because they extensively alter gastrointestinal microbial balance.

The other options listed carry comparatively lower risk. Amoxicillin has a modest association but is not among the highest-risk agents. Aztreonam has limited anaerobic activity and is less disruptive to gut flora. Tobramycin, an aminoglycoside, has minimal impact on intestinal microbiota when administered parenterally and is not commonly associated with CDI.

Recognizing high-risk antimicrobials is essential for antimicrobial stewardship, CDI prevention strategies, and CIC® exam success. Clindamycin is classically tested and should be readily identified as a major CDI risk factor.